CD40.RBDv

N/A

Report date: 2025/04/18 15:19:28

Base Information

Drug NameCD40.RBDv

Drug Alias NameCD40.RBDv

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Vaccine type > Multivalent vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesLinKinVax

China Registration ClassN/A

Develop Information

Active CompaniesVaccine Research Institute (VRI), France

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A